Furthermore, a comparable level of activation and proliferation markers were found (HLA-DR, CD-38, and Ki-67) between QFT-positive study participants and six months of anti-TB treatment from smear-positive pulmonary TB patients. This evidence concerns the gene MKI67 and pulmonary tuberculosis.